AMED Takes Initial Step Toward Out-Licensing First Lead Compound; Now Taking Applications from Companies

The Japan Agency for Medical Research and Development (AMED) began taking applications on July 21 from companies that wish to in-license a lead compound to develop into a treatment for muscle degenerative diseases. This is a research theme of the...read more